{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:20:37Z","timestamp":1787314837627,"version":"build-2736575974"},"reference-count":102,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Heart failure (HF) remains a leading cause of morbidity, hospitalization, and mortality worldwide. Advancement of mechanical circulatory support technology has led to the use of continuous-flow left ventricular assist devices (LVADs), reducing hospitalizations, and improving quality of life and outcomes in advanced HF. Recent studies have highlighted how metabolic and endocrine dysfunction may be a consequence of, or associated with, HF, and may represent a novel (still neglected) therapeutic target in the treatment of HF. On the other hand, it is not clear whether LVAD support, may impact the outcome by also improving organ perfusion as well as improving the neuro-hormonal state of the patients, reducing the endocrine dysfunction. Moreover, endocrine function is likely a major determinant of human homeostasis, and is a key issue in the recovery from critical illness. Care of the endocrine function may contribute to improving cardiac contractility, immune function, as well as infection control, and rehabilitation during and after a LVAD placement. In this review, data on endocrine challenges in patients carrying an LVAD are gathered to highlight pathophysiological states relevant to this setting of patients, and to summarize the current therapeutic suggestions in the treatment of thyroid dysfunction, and vitamin D, erythropoietin and testosterone administration.<\/jats:p>","DOI":"10.3390\/nu13030861","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T21:52:15Z","timestamp":1615153935000},"page":"861","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Endocrine Challenges in Patients with Continuous-Flow Left Ventricular Assist Devices"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8443-2414","authenticated-orcid":false,"given":"Gennaro","family":"Martucci","sequence":"first","affiliation":[{"name":"Department of Anesthesia and Intensive Care, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), 90133 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Pappalardo","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), 90133 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1845-0865","authenticated-orcid":false,"given":"Harikesh","family":"Subramanian","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA 15201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ingoglia","sequence":"additional","affiliation":[{"name":"Section of Anesthesia Analgesia Intensive Care and Emergency, Department of Surgical, Oncological and Oral Science, University of Palermo, 90133 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4745-9308","authenticated-orcid":false,"given":"Elena","family":"Conoscenti","sequence":"additional","affiliation":[{"name":"Infectious Disease and Infection Control Service, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), 90133 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Arcadipane","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), 90133 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Drozd, M., Relton, S.D., Walker, A.M.N., Slater, T.A., Gierula, J., Paton, M.F., Lowry, J., Straw, S., Koshy, A., and McGinlay, M. (2020). Association of heart failure and its comorbidities with loss of life expectancy. Heart.","DOI":"10.1136\/heartjnl-2020-317833"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ehf2.13105","article-title":"Heart failure epidemiology and treatment in primary care: A retrospective cross-sectional study","volume":"8","author":"Rachamin","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/HCO.0b013e328345aff4","article-title":"Destination therapy with left ventricular assist devices: Patient selection and outcomes","volume":"26","author":"Slaughter","year":"2011","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/MAT.0000000000000674","article-title":"Different Clinical Course and Complications in Interagency Registry for Mechanically Assisted Circulatory Support 1 (INTERMACS) Patients Managed With or Without Extracorporeal Membrane Oxygenation","volume":"64","author":"Han","year":"2018","journal-title":"ASAIO J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/eurjhf\/hft059","article-title":"The effect of long-term left ventricular assist device support on myocardial sympathetic activity in patients with non-ischaemic dilated cardiomyopathy","volume":"15","author":"George","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e013278","DOI":"10.1161\/JAHA.119.013278","article-title":"Metabolic Dysfunction in Continuous-Flow Left Ventricular Assist Devices Patients and Outcomes","volume":"8","author":"Nguyen","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/ehf2.12337","article-title":"Left ventricular assist device implantation improves glycaemic control: A systematic review and meta-analysis","volume":"5","author":"Patel","year":"2018","journal-title":"ESC Heart Fail."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.hlc.2019.05.181","article-title":"Implantation of Left Ventricular Assist Device Results in Immediate Improvement of Glucose Metabolism in Patients With and Without Diabetes Mellitus","volume":"29","author":"Goetz","year":"2020","journal-title":"Heart Lung Circ."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"078","DOI":"10.1055\/s-0040-1713084","article-title":"Metabolic and Endocrine Challenges","volume":"42","author":"Martucci","year":"2021","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ahj.2018.07.009","article-title":"Management of cardiogenic shock in acute decompensated chronic heart failure: The ALTSHOCK phase II clinical trial","volume":"204","author":"Morici","year":"2018","journal-title":"Am. Heart J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s00134-017-4954-2","article-title":"Understanding adrenal crisis","volume":"44","author":"Amrein","year":"2018","journal-title":"Intensiv. Care Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/phar.1853","article-title":"Positive Impact of Continuous-Flow Left Ventricular Assist Device Implantation on Glycemic Control in Patients with Type 2 Diabetes Mellitus and Advanced Chronic Systolic Heart Failure","volume":"36","author":"Yen","year":"2016","journal-title":"J. Hum. Pharm. Drug Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e005266","DOI":"10.1161\/CIRCHEARTFAILURE.118.005266","article-title":"Thyroid Dysfunction in Heart Failure and Cardiovascular Outcomes","volume":"11","author":"Kannan","year":"2018","journal-title":"Circ. Heart Fail."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.14797\/mdcj-13-2-60","article-title":"Hyperthyroidism and the Heart","volume":"13","author":"Osuna","year":"2017","journal-title":"Methodist DeBakey Cardiovasc. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","article-title":"Thyroid Disease and the Heart","volume":"116","author":"Klein","year":"2007","journal-title":"Circulation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.vph.2009.10.004","article-title":"Thyroid hormone and chronically unloaded hearts","volume":"52","author":"Ito","year":"2010","journal-title":"Vasc. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/ejcts\/ezt106","article-title":"Thyrotoxicosis-facilitated bridge to recovery with a continuous-flow left ventricular assist device","volume":"44","author":"Letsou","year":"2013","journal-title":"Eur. J. Cardio Thorac. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1161\/01.CIR.97.23.2316","article-title":"Myocyte Recovery After Mechanical Circulatory Support in Humans With End-Stage Heart Failure","volume":"97","author":"Dipla","year":"1998","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11010-006-9323-3","article-title":"Thyroid hormone changes cardiomyocyte shape and geometry via ERK signaling pathway: Potential therapeutic implications in reversing cardiac remodeling?","volume":"297","author":"Pantos","year":"2006","journal-title":"Mol. Cell. Biochem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1055\/s-0030-1255035","article-title":"Thyroid Hormone Receptor \u03b11 Downregulation in Postischemic Heart Failure Progression: The Potential Role of Tissue Hypothyroidism","volume":"42","author":"Pantos","year":"2010","journal-title":"Horm. Metab. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1139\/y2012-031","article-title":"Thyroid hormone and cardiac repair\/regeneration: From Prometheus myth to reality?","volume":"90","author":"Pantos","year":"2012","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s002230001132","article-title":"Exercise-trained young men have higher calcium absorption rates and plasma calcitriol levels compared with age-matched sedentary controls","volume":"67","author":"Zittermann","year":"2000","journal-title":"Calcif. Tissue Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"113955","DOI":"10.1016\/j.bcp.2020.113955","article-title":"Vitamin D attenuates lung injury via stimulating epithelial repair, reducing epithelial cell apoptosis and inhibits TGF-\u03b2 induced epithelial to mesenchymal transition","volume":"177","author":"Zheng","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"ref_24","first-page":"169","article-title":"Effect of high doses of vitamin D supplementation on dengue virus replication, Toll-like receptor expression, and cytokine profiles on dendritic cells","volume":"464","author":"Hernandez","year":"2019","journal-title":"Mol. Cell. Biochem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/IDR.S228336","article-title":"Role Of Vitamin-D Supplementation In TB\/HIV Co-Infected Patients","volume":"13","author":"Ayelign","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/s41430-020-0558-y","article-title":"Vitamin D deficiency 2.0: An update on the current status worldwide","volume":"74","author":"Amrein","year":"2020","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.clnu.2017.08.009","article-title":"When not to use meta-analysis: Analysing the meta-analyses on vitamin D in critical care","volume":"36","author":"Amrein","year":"2017","journal-title":"Clin. Nutr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.2014.13204","article-title":"Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: The VITdAL-ICU randomized clinical trial","volume":"312","author":"Amrein","year":"2014","journal-title":"JAMA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"173510","DOI":"10.1016\/j.ejphar.2020.173510","article-title":"The protective effect of 1,25(OH)2D3 against cardiac hypertrophy is mediated by the cyclin-dependent kinase inhibitor p21","volume":"888","author":"Liu","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.numecd.2016.06.007","article-title":"Calciotropic and phosphaturic hormones in heart failure","volume":"26","author":"Zittermann","year":"2016","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/eurjhf\/hfs002","article-title":"Bone mass loss in chronic heart failure is associated with secondary hyperparathyroidism and has prognostic significance","volume":"14","author":"Terrovitis","year":"2012","journal-title":"Eur. J. Heart Fail."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1016\/j.clnu.2018.11.033","article-title":"The relevance of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentration for postoperative infections and postoperative organ dysfunctions in cardiac surgery patients: The eVIDenCe study","volume":"38","author":"Ney","year":"2019","journal-title":"Clin. Nutr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/eurjhf\/hfs138","article-title":"Dynamics of bone turnover markers in patients with heart failure and following haemodynamic improvement through ventricular assist device implantation","volume":"14","author":"Wu","year":"2012","journal-title":"Eur. J. Heart Fail."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00223-019-00559-4","article-title":"Vitamin D Deficiency: Defining, Prevalence, Causes, and Strategies of Addressing","volume":"106","author":"Cashman","year":"2020","journal-title":"Calcif. Tissue Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e027666","DOI":"10.1136\/bmjopen-2018-027666","article-title":"Importance of vitamin D in acute and critically ill children with subgroup analyses of sepsis and respiratory tract infections: A systematic review and meta-analysis","volume":"9","author":"Cariolou","year":"2019","journal-title":"BMJ Open"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1007\/s00134-009-1642-x","article-title":"Vitamin D deficiency in the intensive care unit: An invisible accomplice to morbidity and mortality?","volume":"35","author":"Lee","year":"2009","journal-title":"Intensiv. Care Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13054-019-2472-z","article-title":"Trying to identify who may benefit most from future vitamin D intervention trials: A post hoc analysis from the VITDAL-ICU study excluding the early deaths","volume":"23","author":"Martucci","year":"2019","journal-title":"Crit. Care"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Zittermann, A., Ernst, J.B., Pilz, S., Dreier, J., Kuhn, J., Knabbe, C., Gummert, J.F., Morshuis, M., and Milting, H. (2016). Calciotropic and Phosphaturic Hormones in End-Stage Heart Failure Patients Supported by a Left-Ventricular Assist Device. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0164459"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00198-017-4312-9","article-title":"Vitamin D supplementation and bone turnover in advanced heart failure: The EVITA trial","volume":"29","author":"Zittermann","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_41","first-page":"1","article-title":"Vitamin D deficiency as a risk factor for infection, sepsis and mortality in the critically ill: Systematic review and meta-analysis","volume":"18","author":"Groeneveld","year":"2014","journal-title":"Crit. Care"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Martucci, G., Volpes, R., Panarello, G., Tuzzolino, F., Di Carlo, D., Ricotta, C., Gruttadauria, S., Conaldi, P.G., Luca, A., and Amrein, K. (2020). Vitamin D Levels in Liver Transplantation Recipients and Early Postoperative Outcomes: Prospective Observational DLiverX Study. Clin. Nutr.","DOI":"10.1016\/j.clnu.2020.10.027"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/MOT.0000000000000709","article-title":"Innate immunity in ischemia-reperfusion injury and graft rejection","volume":"24","author":"Nakamura","year":"2019","journal-title":"Curr. Opin. Organ. Transplant."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41423-019-0216-2","article-title":"The innate immune response to allotransplants: Mechanisms and therapeutic potentials","volume":"16","author":"Ochando","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"R304","DOI":"10.1530\/EC-18-0184","article-title":"Vitamin D and critical illness: What endocrinology can learn from intensive care and vice versa","volume":"7","author":"Amrein","year":"2018","journal-title":"Endocr. Connect."},{"key":"ref_46","unstructured":"Del Valle, H.B., Yaktine, A.L., Taylor, C.L., and Ross, A.C. (2011). Dietary Reference Intakes for Calcium and Vitamin D, The National Academies Press."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/ajcn\/77.1.204","article-title":"Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol","volume":"77","author":"Heaney","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/ajcn\/85.1.6","article-title":"Risk assessment for vitamin D","volume":"85","author":"Hathcock","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1359\/jbmr.2000.15.6.1113","article-title":"Effects of a Short-Term Vitamin D and Calcium Supplementation on Body Sway and Secondary Hyperparathyroidism in Elderly Women","volume":"15","author":"Pfeifer","year":"2000","journal-title":"J. Bone Mineral Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know","volume":"96","author":"Ross","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"EFSA Panel on Dietetic Products, Nutrition and Allergies (2012). Scientific Opinion on the Tolerable Upper Intake Level of vitamin D. EFSA J., 10, 2813.","DOI":"10.2903\/j.efsa.2012.2813"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: An international pooled analysis","volume":"165","author":"Klip","year":"2013","journal-title":"Am. Heart J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cjca.2015.06.009","article-title":"The Efficacy and Safety of Iron Supplementation in Patients With Heart Failure and Iron Deficiency: A Systematic Review and Meta-analysis","volume":"32","author":"Qian","year":"2016","journal-title":"Can. J. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ejhf.823","article-title":"Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: An individual patient data meta-analysis","volume":"20","author":"Anker","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.bbagen.2008.09.008","article-title":"The role of iron in mitochondrial function","volume":"1790","author":"Levi","year":"2009","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/ejhf.1154","article-title":"Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function","volume":"20","author":"Hoes","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"28","DOI":"10.15420\/cfr.2018:6:2","article-title":"Iron Therapy in Heart Failure: Ready for Primetime?","volume":"4","author":"Mordi","year":"2018","journal-title":"Card. Fail. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/jamacardio.2016.1161","article-title":"Prevalence and Outcomes of Anemia and Hematinic Deficiencies in Patients With Chronic Heart Failure","volume":"1","author":"Cleland","year":"2016","journal-title":"JAMA Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ejhf.84","article-title":"The additive burden of iron deficiency in the cardiorenal-anaemia axis: Scope of a problem and its consequences","volume":"16","author":"Klip","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/00015385.2017.1351239","article-title":"Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction","volume":"73","author":"Martens","year":"2017","journal-title":"Acta Cardiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.jacc.2006.08.034","article-title":"Etiology of Anemia in Patients With Advanced Heart Failure","volume":"48","author":"Nanas","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: An ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.hfc.2010.02.002","article-title":"Treatment with Iron of Patients with Heart Failure With and Without Anemia","volume":"6","author":"Jelani","year":"2010","journal-title":"Heart Fail. Clin."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa1214865","article-title":"Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure","volume":"368","author":"Swedberg","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ahj.2004.09.047","article-title":"Rationale\u2014Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease","volume":"149","author":"Mix","year":"2005","journal-title":"Am. Heart J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/eurjhf\/hfp110","article-title":"Significance of anaemia in patients with advanced heart failure receiving long-term mechanical circulatory support","volume":"11","author":"Vrtovec","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jchf.2014.08.005","article-title":"Clinical Outcomes With Use of Erythropoiesis Stimulating Agents in Patients With the HeartMate II Left Ventricular Assist Device","volume":"3","author":"Nassif","year":"2015","journal-title":"JACC Heart Fail."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Yeap, B.B., and Dwivedi, G. (2020). Androgens and Heart Failure: New Observations Illuminating an Aging Conundrum. J. Clin. Endocrinol. Metab.","DOI":"10.1210\/clinem\/dgaa676"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1152\/physrev.2001.81.3.1269","article-title":"Nuclear Hormone Receptors and Gene Expression","volume":"81","author":"Aranda","year":"2001","journal-title":"Physiol. Rev."},{"key":"ref_71","unstructured":"Nassar, G.N., and Leslie, S.W. (2020). Physiology, Testosterone, StatPearls Publishing LLC.. StatPearls PublishingCopyright 2020."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0300-8932(09)73119-7","article-title":"Sex hormone-binding globulin and heart failure: A passive carrier of steroid hormones or an active hormone itself?","volume":"62","author":"Jankowska","year":"2009","journal-title":"Rev. Espa\u00f1ola Cardiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"H1210","DOI":"10.1152\/ajpheart.01210.2010","article-title":"Androgen stimulates endothelial cell proliferation via an androgen receptor\/VEGF\/cyclin A-mediated mechanism","volume":"300","author":"Cai","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1210\/jc.2006-0763","article-title":"Reduced Number of Circulating Endothelial Progenitor Cells in Hypogonadal Men","volume":"91","author":"Foresta","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1210\/en.2009-1048","article-title":"Androgen Receptor-Dependent Activation of Endothelial Nitric Oxide Synthase in Vascular Endothelial Cells: Role of Phosphatidylinositol 3-Kinase\/Akt Pathway","volume":"151","author":"Yu","year":"2010","journal-title":"Endocrinology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1210\/me.2010-0138","article-title":"Research Resource: The Androgen Receptor Modulates Expression of Genes with Critical Roles in Muscle Development and Function","volume":"24","author":"Wyce","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1210\/jc.2002-021231","article-title":"Testosterone Dose-Dependently Increases Maximal Voluntary Strength and Leg Power, but Does Not Affect Fatigability or Specific Tension","volume":"88","author":"Storer","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1530\/JOE-15-0506","article-title":"Supra-physiological dose of testosterone induces pathological cardiac hypertrophy","volume":"229","author":"Pirompol","year":"2016","journal-title":"J. Endocrinol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1161\/CIRCULATIONAHA.107.688044","article-title":"Response to Letter Regarding Article, \u201cAnabolic Deficiency in Men With Chronic Heart Failure: Prevalence and Detrimental Impact on Survival\u201d","volume":"115","author":"Jankowska","year":"2007","journal-title":"Circulation"},{"key":"ref_80","first-page":"1381","article-title":"Sex hormone-binding globulin: A new marker of disease severity and prognosis in men with chronic heart failure","volume":"62","author":"Tornel","year":"2009","journal-title":"Rev. Espa\u00f1ola Cardiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/aja.2011.26","article-title":"Testosterone level and mortality in elderly men with systolic chronic heart failure","volume":"13","author":"Wu","year":"2011","journal-title":"Asian J. Androl."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1016\/j.transproceed.2019.07.028","article-title":"Effect of Testosterone Level on Mortality in Patients With Left Ventricular Assist Device","volume":"51","author":"Simsek","year":"2019","journal-title":"Transplant. Proc."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0735-1097(97)00262-3","article-title":"Tumor Necrosis Factor and Steroid Metabolism in Chronic Heart Failure: Possible Relation to Muscle Wasting","volume":"30","author":"Anker","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/CIRCULATIONAHA.107.719005","article-title":"Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study","volume":"116","author":"Khaw","year":"2007","journal-title":"Circulation"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1210\/jc.2011-1137","article-title":"Clinical review: Endogenous testosterone and mortality in men: A systematic review and meta-analysis","volume":"96","author":"Araujo","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/hrt.2010.210757","article-title":"Endogenous testosterone and cardiovascular disease in healthy men: A meta-analysis","volume":"97","author":"Ruige","year":"2010","journal-title":"Heart"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e000272","DOI":"10.1161\/JAHA.113.000272","article-title":"Testosterone and the Cardiovascular System: A Comprehensive Review of the Clinical Literature","volume":"2","author":"Oskui","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e3798","DOI":"10.1210\/clinem\/dgaa500","article-title":"Sex Hormones and Incident Heart Failure in Men and Postmenopausal Women: The Atherosclerosis Risk in Communities Study","volume":"105","author":"Zhao","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/eurjhf\/hfr007","article-title":"Low free testosterone is associated with heart failure mortality in older men referred for coronary angiography","volume":"13","author":"Wehr","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2009.04.078","article-title":"Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study","volume":"54","author":"Caminiti","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/eurheartj\/ehi443","article-title":"Testosterone therapy in men with moderate severity heart failure: A double-blind randomized placebo controlled trial","volume":"27","author":"Malkin","year":"2005","journal-title":"Eur. Heart J."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/hrt.2003.014639","article-title":"Testosterone treatment for men with chronic heart failure","volume":"90","author":"Pugh","year":"2004","journal-title":"Heart"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jacc.2010.03.090","article-title":"Testosterone therapy in women with chronic heart failure: A pilot double-blind, randomized, placebo-controlled study","volume":"56","author":"Iellamo","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCHEARTFAILURE.111.965632","article-title":"Testosterone supplementation in heart failure: A meta-analysis","volume":"5","author":"Toma","year":"2012","journal-title":"Circ. Heart Fail."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cardfail.2014.08.011","article-title":"Functional Status in Left Ventricular Assist Device\u2013Supported Patients: A Literature Review","volume":"20","author":"Abshire","year":"2014","journal-title":"J. Card. Fail."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0960-0760(03)00360-1","article-title":"Sources of estrogen and their importance","volume":"86","author":"Simpson","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1210\/en.2009-1456","article-title":"Minireview: Rapid Actions of Sex Steroids in the Endothelium","volume":"151","author":"Chow","year":"2010","journal-title":"Endocrinology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.steroids.2013.01.003","article-title":"Protective actions of progesterone in the cardiovascular system: Potential role of membrane progesterone receptors (mPRs) in mediating rapid effects","volume":"78","author":"Thomas","year":"2013","journal-title":"Steroids"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13293-017-0152-8","article-title":"The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy","volume":"8","author":"Iorga","year":"2017","journal-title":"Biol. Sex. Differ."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/aje\/kwm214","article-title":"Hormones and heart disease in women: The timing hypothesis","volume":"166","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"(2013). ACOG Committee Opinion No. 565. Hormone therapy and heart disease. Obstet. Gynecol., 121, 1407\u20131410.","DOI":"10.1097\/01.AOG.0000431053.33593.2d"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jchf.2017.06.014","article-title":"INTERMACS Analysis of Stroke During Support With Continuous-Flow Left Ventricular Assist Devices","volume":"5","author":"Acharya","year":"2017","journal-title":"JACC Heart Fail."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/3\/861\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:33:53Z","timestamp":1760160833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/3\/861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":102,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["nu13030861"],"URL":"https:\/\/doi.org\/10.3390\/nu13030861","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,5]]}}}